autologous tumor lysate-pulsed dendritic cell vaccine (Capital Medical University/Duke University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameautologous tumor lysate-pulsed dendritic cell vaccine (Capital Medical University/Duke University)
Drug Alias NameDendritic Cell vaccine (CMU/Duke University)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine +[5] 
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCapital Medical University
China Registration ClassN/A

Develop Information

Active CompaniesDuke UniversityCapital Medical University
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A